Lars B. Abrahmsen
Senior VP & Chief Scientific OfficerDr. Lars B. Abrahmsen, Ph.D. serves as Senior Vice President and Chief Scientific Officer at Aprea Therapeutics, Inc. since October 2014. Dr. Abrahmsen serves as Senior Vice President and Chief Scientific Officer at Aprea Therapeutics AB since October 2014. Dr. Abrahmsen served as Senior Vice President of Protein Therapeutics at Algeta ASA from November 15, 2010 to 2013. He was responsible for the development of Algeta's Thorium platform and for building and overseeing the preclinical development of a pipeline of alpha-pharmaceutical candidates based on tumor-targeted thorium-227 conjugates. He has a wealth of experience in protein engineering, including monoclonal antibody production and conjugation, gained at Affibody and at Pharmacia Corporation, where he established their phage display and antibody cloning capabilities. He served at Genentech from 1988 to 1990. He joined Algeta from Affibody Medical AB (publ), where he served as Chief Scientific Officer since 2004 till 2010. Dr. Abrahmsen joined Affibody AB from Swedish Orphan Biovitrum AB, where he served as Senior Project Team Leader, where he was responsible for all steps of the chain ranging from high throughput screening to in vivo pharmacology. Dr. Abrahmsen served as a Member of Scientific Advisory Board of Affibody Medical AB (publ). Dr. Abrahmsen earned his Ph.D. in Biochemistry from the Royal Institute of Technology in Stockholm in 1988 and M.S. in Chemistry from the Royal Institute of Technology in Stockholm.
Positions
- Company NameAprea Therapeutics, Inc.Stock CodeAPREPositionSenior VP & Chief Scientific OfficerColleagues
- OGOren GiladCo-Founder, CEO, President & Director
- RPRichard PetersIndependent Chairperson of the Board
- JPJohn P. HamillSenior VP, CFO, Principal Accounting Officer & Secretary
- BWBrian WileySenior Vice President of Corporate Development & Strategy
- MAMichel AfarganHead of Pharmacology Development
- MJMichael J. GrissingerIndependent Director
- JBJohn B. HennemanIndependent Director
- RPRifat PamukcuIndependent Director
